Read + Share
Amedeo Smart
Independent Medical Education
. Correction to: "Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial". Headache 2024 Feb 26. doi: 10.1111/head.14691.PMID: 38407505
Email
LinkedIn
Facebook
Twitter
Privacy Policy